Device / Technology News

RSS

AlloSource named CEBA finalist in the Samaritan Institute category

AlloSource, one of the nation's largest non-profit providers of skin, bone and soft tissue allografts for use in surgical procedures and the world's largest processor of live cellular bone growth substitutes, today announced that is has been selected as a finalist in the 2010 Colorado Ethics in Business Alliance (CEBA) Awards, in the Samaritan Institute category honoring non-profits.

18 Dec 2009

MedLink International guarantees to meet "Meaningful Use" guidelines for its EHR products

MedLink International, Inc., a provider of electronic health record (EHR) solutions to the ambulatory care market announced today it will guarantee that its qualified EHR products will meet the "Meaningful Use" guidelines to allow its providers to receive the federal incentives available under the HITECH provisions of the American Recovery and Reinvestment Act (ARRA).

18 Dec 2009

Biovator and BASF sign collaboration agreement to develop In Vitro test systems

The Sweden-based biotech company Biovator and the global chemical industry leader BASF have signed a collaboration agreement for final development of In Vitro test systems capable of identifying the potential of chemical compounds to induce allergic reaction in humans. The agreement also includes a five-year BASF option of final product deliveries.

18 Dec 2009

CTS awarded new development and production program for piezoelectric micro actuators

CTS Corporation today announced that CTS Electronic Components was awarded a major new development and production program for piezoelectric micro actuators for data storage devices (hard disk drives). Production is anticipated to begin in the fourth quarter 2010 with total revenues over the next three years to be approximately $14 million and over $10 - $12 million annually thereafter.

18 Dec 2009

Triage NGAL bedside blood test helps identify AKI risk: New study

According to a new study published last week in Intensive Care Medicine, a novel bedside blood test measured in critically ill patients being admitted to the intensive care unit can help to identify which patients are at risk for acute kidney injury (AKI). The study carried out in Vicenza, Italy, tested blood samples collected during admission to the ICU using the Triage® NGAL Test, a product currently sold by Inverness Medical Innovations, Inc. outside of the United States.

18 Dec 2009

TriZetto Group chooses RTM Consulting's Skills Development and Training Services

Cincinnati-based RTM Consulting, the leading provider of Resource Management Solutions for consulting and professional services organizations in the technology sector, announced today that The TriZetto Group, Inc. has selected RTM Consulting's Skills Development and Training Services to integrate into its internal Associate Level Professional Skills Certification Program.

18 Dec 2009

Advanced Medical Diagnostics SA to open 15 Tissue Differentiation Diagnostic Centres

Advanced Medical Diagnostics SA, a privately held company committed to providing innovative computer-aided solutions (HistoScanning™) that improve the diagnostic interpretation of ultrasound scans, today announced a collaboration with the BUND-DER-UROLOGEN for the opening of 15 Tissue Differentiation Diagnostic Centres.

18 Dec 2009

Biovista and Novus Biologicals sign contract for accessing Biovista's BEA literature mining platform

Biovista Inc. today announced the signing of a contract with Novus Biologicals for access to Biovista's BEA literature mining platform. BEA will be used to power Novus Explorer, a new service that Novus Biologicals is offering to visitors of its web site.

18 Dec 2009

NiTi Surgical Solutions' ColonRing used for the first time in a colorectal surgery in China

NiTi™ Surgical Solutions, an innovative surgical device company, today announced that its ColonRing™, the first major advance in closure for gastrointestinal surgery in more than 30 years, has been used for the first time in a colorectal surgery in China. The ColonRing anastomosis device was launched in the United States in May 2008 and has been successfully applied in thousands of patients.

18 Dec 2009

Pico-Tesla commences enrollment in its Magneceutical therapy study for type 2 diabetes

Pico-Tesla, The Magneceutical™ Therapy Company, announced today that it has enrolled the first seven patients for a randomized, double-blind, placebo-controlled Pilot Study of persons who have type 2 diabetes, the most common form of diabetes. The Pilot Study seeks to determine whether the application of magnetic fields generated by the Company’s patented Resonator™ system can be effective as an adjunctive therapy to oral medications in reducing hemoglobin A1c levels.

18 Dec 2009

Survey indicates low EMR use among U.S. physicians

Washington can encourage physicians to buy electronic medical record systems, but it is the vendors and hospitals that affiliate with physicians that will ultimately determine if they go electronic, according to a new report from healthcare market research publisher Kalorama Information.

18 Dec 2009

Brachytherapy for lung cancer

A 58-year-old man who lives in Corona, Queens came to the emergency room of New York Hospital Queens (NYHQ) with extreme pain and tingling in his left arm. Although he did not realize it at the time, he had lung cancer. Recently, he made medical history as the first patient in the United States to be treated for lung cancer through the use of radioactive pellets placed directly in the tumor, and today his recovery is going well. Known as brachytherapy, this treatment approach is commonly used to treat prostate cancer.

18 Dec 2009

LifeNet Health distributes 40,040 allograft bio-implants to patients in November 2009

According to recent statistics, LifeNet Health was able to distribute 40,040 allograft bio-implants to patients in November 2009, an unprecedented number in LifeNet Health's 27-year history.

18 Dec 2009

BioMS Medical invests in Spectral Diagnostics to advance treatment for sepsis

Spectral Diagnostics Inc. and BioMS Medical Corp. today announced that BioMS Medical ("BioMS") and a syndicate of investors have invested $14 million in Spectral Diagnostics ("Spectral", or the "Company") to advance Toraymyxin(TM), a treatment for severe sepsis, towards regulatory approval and commercialization in the United States.

18 Dec 2009

New technology sheds light on intracellular transport

Using new technology developed in his University of Oregon lab, chemist Andrew H. Marcus and his doctoral student Eric N. Senning have captured what they describe as well-orchestrated, actin-driven, mitochondrial movement within a single cell.

18 Dec 2009

Interactive health assessment system from RedBrick Health

RedBrick Health, the Health EarningsSM company, today announced the launch of its own next-generation, highly interactive health assessment. Integral to RedBrick’s Health Earnings System, the company’s new health assessment is compact, conversational and graphical, all significant departures from conventional health assessments.

18 Dec 2009

Study results of Impella 2.5 circulatory assist device in high-risk PCI procedures published

Results from the Europella registry, evaluating the safety and feasibility of the Abiomed, Inc. Impella 2.5 circulatory assist device in high-risk percutaneous coronary intervention (PCI) procedures have been published in the December 15 issue of the Journal of the American College of Cardiology (JACC).

18 Dec 2009

New statement on breast cancer by ACS underscores value of post-surgical radiation therapy

A new statement on breast cancer by the American College of Surgeons (ACS) underscores the value of an advanced approach to post-surgical radiation therapy provided by the Breast Clinic of Memphis.

18 Dec 2009

Healthnostics' MedGuardian system targets the needs of hospitalists

Healthnostics, Inc., a medical and biotechnology analytics company today announced the inclusion of a hospitalist (hospital employed physicians, physician assistants and nurse practitioners) focus for the MedGuardian patient clinical monitoring and risk management system.

18 Dec 2009

Practice Fusion continues to be the fastest growing EHR community in the US

Practice Fusion today announced that the company's user base has grown 400% in 2009 to surpass 25,000 medical professionals. Practice Fusion continues to be the fastest growing Electronic Health Record (EHR) community in the US, serving the needs of family practice and private practice physicians across the country.

18 Dec 2009

Device / Technology News

AlloSource named CEBA finalist in the Samaritan Institute category

MedLink International guarantees to meet "Meaningful Use" guidelines for its EHR products

Biovator and BASF sign collaboration agreement to develop In Vitro test systems

CTS awarded new development and production program for piezoelectric micro actuators

Triage NGAL bedside blood test helps identify AKI risk: New study

TriZetto Group chooses RTM Consulting's Skills Development and Training Services

Advanced Medical Diagnostics SA to open 15 Tissue Differentiation Diagnostic Centres

Biovista and Novus Biologicals sign contract for accessing Biovista's BEA literature mining platform

NiTi Surgical Solutions' ColonRing used for the first time in a colorectal surgery in China

Pico-Tesla commences enrollment in its Magneceutical therapy study for type 2 diabetes

Survey indicates low EMR use among U.S. physicians

Brachytherapy for lung cancer

LifeNet Health distributes 40,040 allograft bio-implants to patients in November 2009

BioMS Medical invests in Spectral Diagnostics to advance treatment for sepsis

New technology sheds light on intracellular transport

Interactive health assessment system from RedBrick Health

Study results of Impella 2.5 circulatory assist device in high-risk PCI procedures published

New statement on breast cancer by ACS underscores value of post-surgical radiation therapy

Healthnostics' MedGuardian system targets the needs of hospitalists

Practice Fusion continues to be the fastest growing EHR community in the US

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Edoardo Fabini

Latest News